Treatment of Diabetic Foot Ulcer

A NANO PHOTOTHERANOSTIC APPROACH TO TREAT DIABETIC FOOT ULCER

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052838

Enrollment

Registered

2023-05-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Silver Gold TBO complex Nano composite with Photodynamic therapy: Task 1 Approval for clinical trial from the licencing authority and ethics committee. Task 2 Patient screening for incl

Eligibility

Inclusion criteria

Inclusion criteria: Patients with diabetic foot ulcer > 18 years of age, Wegner grade 2 and 3

Exclusion criteria

Exclusion criteria: 1. Presence of critical Peripheral arterial disease 2. Shock or sepsis 3. Severe hypertension 4. Congestive heart failure 5. Established coronary artery disease 6. Severe hypertension 7. End stage kidney or liver disease

Design outcomes

Primary

Measure	Time frame
Reduction in wound area by 50%Timepoint: followup at 2, 4,6, 8 and 12 weeks during treatment	—

Secondary

Measure	Time frame
50% reduction in wound areaTimepoint: 2 weeks 4 weeks and 6 weeks	—

Countries

India

Contacts

Public ContactAsad U Khan

Interdisciplinary biotechnology unit, AMU, Aligarh

Asad.k@rediffmail.com9837021912

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026